Koppel Adam — SEC Form 4 filings
SEC reporting owner CIK 1578965. 6 Form 4 filings on record with FilingPulse; latest filed 2026-04-20.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-12 to 2026-04-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,562,500 shares, $25,000,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 1,562,500 shares @ $16.00 ($25,000,000) in Kailera Therapeutics, Inc., filed 2026-04-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | Director, 10% owner | 1 | 1 leg · 1,562,500 sh · $25,000,000 | — | 5 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | Director, 10% owner | 2 | — | — | 5 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 2 | — | — | 1 |
| Solid Biosciences Inc. (SLDB) | Director, 10% owner | 1 | — | — | 1 |
Form 4 filings — Koppel Adam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-20 | 4 | Kailera Therapeutics, Inc. (KLRA) | Conversion (C): 16,875,000 · Conversion (C): 4,145,768 · Purchase (P): 1,562,500 @ $16 · Conversion (C): 16,875,000 (derivative) @ $0 · Conversion (C): 4,145,768 (derivative) @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Foghorn Therapeutics Inc. (FHTX) | Holdings only — no transactions reported | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 3,282 · Disposition to issuer (D): 10,461 · Disposition to issuer (D): 65,679,781 · Disposition to issuer (D): 80,189 (derivative) | EDGAR |
| 2024-06-28 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $5.52 | EDGAR |
| 2024-06-07 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 10,461 | EDGAR |
| 2024-01-12 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 904,160 @ $5.53 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1578965 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →